This event will provide a platform for international and regional government regulators, generic pharmaceutical industry leaders to convene to exploit opportunities offered by the Asia’s emerging generic markets and explore the latest trends, regulation changes, outsourcing and partnership opportunities, operational and marketing best practices, life cycle management strategies and latest innovation of value added generic medicines.